@article{BöhmButlerKrawczykMahfoudHaringFilippatosFerreiraPocockBrueckmannOfstadSchülerWannerVermaPackerAnker_2023,
title={Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial},
author={Böhm, Michael and Butler, Javed and Krawczyk, Marcin Jan and Mahfoud, Felix and Haring, Bernhard and Filippatos, Gerasimos and Ferreira, João Pedro and Pocock, Stuart J. and Brueckmann, Martina and Ofstad, Anne Pernille and Schüler, Elke and Wanner, Christoph and Verma, Subodh and Packer, Milton and Anker, Stefan D.},
issn={1879-0844},
doi={http://dx.doi.org/10.22028/D291-40739},
series={8},
volume={25},
publisher={Wiley},
journal={European Journal of Heart Failure},
year={2023}
}